FDA Investigator Peter Kessler, PhD

Peter Kessler, PhD has conducted inspections on 227 sites in 6 countries as of 28 Oct 2021. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
227
Last Inspection Date:
28 Oct 2021
Investigator Role:
FDA Investigation Participant
Redica ID:
100000855
Countries of Inspections:
United States of America, Greece, Hungary, Spain, Canada, Italy
FDA Investigators that have inspected at least one site in common with Peter Kessler, PhD:
Aaron L Dunbar, Abby M Miller, Alan D Grupe, Alan R Condon, Albert F Peacock, PhD, Alexander M Kay, Alicia Aborg Borm, Amy R Glynn, Ana Djurdjevic, Andrea A Branche, Andrea George, PhD, Andrew K Haack, PhD, Angel K Sandhu, Anh M Lac, Anita Narula, PhD, Ava M Bowman, Avery J Dennis, Barbara J Rincon, Barbara J Wilcox, PhD, Beau R Lamb, Blondell W Johnson, Bobbi J Miller, Bonnie L Menzel, Brenda G Stewart Munoz, Brenda K Alford, Brenda L Reihing, Brian Sanders, Bruce R Burrell, Bryan Baker, Bryce A May, Bryce E Mansfield, Burnell M Henry, Calvin B Koerner, Camille Bennett Hoffman, Carl A Anderson, Carl Lee, Carole L Jones, Catherine J Laufmann, Ce'nedra M Martin, Celeta S Coves, Chava Kimchi Sarfaty, PhD, Christopher D Rush, Christopher R Czajka, Christopher S Genther, Connie L Hannon Rabel, Cynthia A Harris, MD, RN, Cynthia L Gorveatt, Dan G Eisenbrey, Daniel J Roberts, Danielle Lyke, Darla J Christopher, Deborah A Nebenzahl, Deborah Kleinfeld, Decarlos A Gomez, Dennis G Kawabata, Dennis R Hudson, Diana L Ayala, Diane Cvan Leeuwen, Diane Hall, Dianna D Wardlow Dotter, Dirk L Lincoln, Dolores E Price, Donald B Mckechnie, Donald W Jehn, Douglas J Scott, Dr. Mark J Seaton, PhD, Dr. Ralph M Bernstein, PhD, Dustin R Abaonza, Dylan R Jock, Edward D Harris, Eliezar Ramos, Elmina E Akwo, Emily B Camire, Emily Shacter, Eric C Milstead, Eric L Dong, BS, Garrad R Poole, Gary C Pecic, Jr, Gene R Gunn, Gerald Feldman, Gerald M Feldman, PhD, Gina C Collins, Gloria A Milster, Gloria J Baca, MS, Hanna L Potter, Harmon M Blanch, Heika R Tait, Henry K Lau, Hughes, Isaiah D Isakson, Jacob N Hamilton, Jacqueline Mdiaz Albertini, James D Hildreth, James E Trabert, James R Evans, Jane S Wernberg, Jason T Lovelady, Jean C Colon Lopez, Jeanne Fringer, PhD, Jeanne M Weishaar, Jeffrey M Watson, Jennifer A Baker, Jesse A Vazquez, Jessica L Walters Moell, Jinkee Mvila Binayug, Joan T Briones, Jocelyn E Massey, Joey V Quitania, John A Iwen, John W Banks, Jonathan T Little, Jose A Torres, Joseph Kutze, PhD, Joseph P Iser, MD, Joshua S Hunt, Julia E Chervoni, Julian C Hanson, Ka L Wong, Kaarin M Slotte, Katherine L Arnold, Kathleen Chmura Shaffer, Kathleen S Tormey, Kathryn A Krentz, Keegan B Mixon, Kelly D Moore, Kelsey A Hustedt, Kenneth S Boehnen, Kevin P Foley, Kimberly A Dux, Kimberly Jproctor Jones, Kip J Hanks, Kirsten L Vadheim, PhD, Lakisha M Williams, Lance Mde Souza, MBA, Laura Kathryn, Lauren E Skokan, Lauren E Swantko, Laurie P Norwood, Laverne Puckett, LCDR Debra Emerson, LCDR Ismael Olvera, IV, LCDR Jennifer H Rhyu, Leigh Anne Myers, Lesley A Swanson, Linh Tu, Lisa K Capron, Lisa M Althar, Lisa T Michel, Lori J Silverstein, Lynn L Wong, Mabel M Lee, Maida Henesian (NMI), Maira P Brading, Marc A Jackson, Jr, Margo C Jones, Marie K Kinkade, Marion W Nadeau, Mariza M Jafary, Mark E Imsland, Mark E Moen, Mark W Babbitt, Marsha L Mccauley, Marsha W Major, Mary Ewilkerson Brinsko, Matthew R Barr, Melissa J Holz, Melissa J Ireland, Michael J Donovan, Michael S Hudson, Michael S Valenzuela, Michael Shanks, MS, Michael T Cyrus, Michele L Forster, PhD, Michelle Rfrazier Jessen, PhD, Mihaly S Ligmond, Min Shanmabel Liu, Nancy A Saxenian Emmons, Nancy E Byerly, Nayan J Patel, Ngoc Lan T Nguyen, Nicholas L Hunt, Nicholas Obiri, PhD, Omotunde O Osunsanmi, Ounchith J Phabmixay, Patrick R Brown, Paul F Rader, Paul M Chefor, Paula A Trost, Peter E Baker, Prabhu P Raju, Ramon Lgonzalez Prieto, Raymond T Oji, Rebecca Rodriguez, Rebecca T Davis, Richard A Martin, Richard G Runyon, Richard Heath Coats, Richard L Bartlett, Richard T Riggie, Riley C Myers, PhD, Rita E Luttrell, Robert A Williams, Robert B Shibuya, MD, Robert D Tollefsen, Robert M Tillman, Rocco C Black, Roger F Zabinski, Ronald E Gill, Ronda Rloyd Jones, Rose Ashley, S Lori Brown, PhD MPH, Sandra K Wangen, Sandra S Saniga, Sarah J Cullen, Scott N Lim, Scott Reynolds, Scott W Fox, Serge L Beaucage, Sharon I Gundersen, Sheilyn H Huang, Shelagh D Schopen, Shelley H Beausoleil, Sherri J Jackson, Sherrie L Krolczyk, Sidney B Priesmeyer, Stephanie A Slater, MS, Stephen R Souza, Stuart W Russell, Sunitha K Rajaram, PhD, Sunny R Muir, Susanne M Richardson, MS RAC, Thao T Kwan, Thea C Grome, Thomas C Mclean, CFS, Thuy T Nguyen, LCDR, Timothy C Grome, Tracy K Li, Travis S Bradley, Truong Xuan Nguyen (Andy), Vanessa Y Gelsey, PhD, Vanessa Y Jacobs, Victoria V Bot, Vitaliy N Guyvan, Walden H Lee, William J Foust, William V Millar, Yi Wang, PhD, Young M Yoon, Yvette Mlacour Davis, Yvonne C Wilkes, Zachary P Wachlarowicz, Ze Peng

Peter Kessler, PhD's Documents

Publish Date Document Type Title
May, 2019 FDA 483 NeoBiotech Global Corporation - Form 483, 2019-05-13
November, 2017 EIR Bloodworks - EIR, 2017-11-02
March, 2019 FDA 483 Bloodworks - Form 483, 2019-05-20
August, 2015 FDA 483 Response Hans D. Ochs, MD - Form 483R, 2015-08-17
May, 2014 FDA 483 Nathan M. Bass, MD, PhD - Form 483, 2014-05-09
April, 2013 FDA 483 Neil Josephson, MD - Form 483, 2013-04-30
August, 2015 EIR Hans D. Ochs, MD - EIR, 2015-08-05
January, 2018 EIR Emmett F. Branigan, MD, PS, Inc - EIR, 2018-01-31
June, 2019 FDA 483 Puget Sound Drug Corporation dba Key Pharmacy and Compounding Center - Form 483, 2019-06-13
August, 2015 FDA 483 Hans D. Ochs, MD - Form 483, 2015-08-05
October, 2014 FDA 483 Professor Meletios A. Dimopoulos, MD - Form 483, 2014-10-23
August, 2019 FDA 483 PlasmaLab International, Inc. - Form 483, 2019-08-15
April, 2014 EIR Constance Mao, MD - EIR, 2014-04-14
March, 2018 EIR In VitroTech Labs, Inc. - EIR, 2018-03-21
March, 2018 FDA 483 In VitroTech Labs, Inc. - Form 483, 2018-03-21
February, 2019 FDA 483 ORM Fertility, LLC. - Form 483, 2019-02-14
May, 2019 FDA 483 Bloodworks - Form 483, 2019-05-10
April, 2019 FDA 483 LifeNet Health Northwest, LLC - Form 483, 2019-04-11
January, 2018 FDA 483 Emmett F. Branigan, MD, PS, Inc - Form 483, 2018-01-31
February, 2020 FDA 483 Sound Fertility Care PLLC - Form 483, 2020-02-06
June, 2019 FDA 483 Poma Fertility, LLC - Form 483, 2019-06-19
February, 2020 FDA 483 Pacific Northwest Fertility and IVF Specialists, PLLC - Form 483, 2020-02-18
September, 2021 FDA 483 Tacoma-Pierce County Blood Bank - Form 483, 2021-09-09
October, 2017 EIR Sightlife - EIR, 2017-10-13
April, 2013 EIR Neil Josephson, MD - EIR, 2013-04-30
April, 2013 FDA 483 Response Neil Josephson, MD - Form 483R, 2013-05-17
April, 2014 FDA 483 Constance Mao, MD - Form 483, 2014-04-14
July, 2021 FDA 483 Bloodworks - Form 483, 2021-07-16
September, 2021 FDA 483 CorneaGen LLC - Form 483, 2021-09-24
May, 2014 EIR Nathan M. Bass, MD, PhD - EIR, 2014-05-09
September, 2019 FDA 483 GenTrac Inc. - Form 483, 2019-09-12
October, 2015 FDA 483 Tamas Masszi, M.D., Ph.D. - Form 483, 2015-10-16

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more